Bias Mitigation Training for End-of-Life Care
(BRiDgE-Sim Trial)
Trial Summary
What is the purpose of this trial?
This study aims to determine the ways in which clinician implicit racial biases affect clinician communication with family members of patients near the end of life and to test a novel physician training intervention to reduce the effects of implicit racial bias on quality of communication. Phase 1: A sample of 50 physicians who care for seriously ill patients, including oncologists, critical care physicians and hospital-based internists will participate in a simulated clinical encounter with a Black standardized family member (actor) of a hypothetical case patient. Measures of implicit and explicit bias will be correlated with verbal and nonverbal communication behavior. Phase 2: This is a 2-arm randomized feasibility pilot of an intervention to mitigate the effects of clinician implicit bias on communication behavior. Physicians who treat patients with serious illness including oncologists, critical care physicians and hospital-based internists will be recruited to participate in a communication training session to reduce the effects of implicit bias or a control training session focusing only on communication skills. Their communication behavior will be videotaped during a simulated encounter with a Black standardized family member (actor) of a hypothetical patient with serious illness before and after the training sessions. The communication behavior before and after the training session will be compared between physicians that received the communication skills only intervention versus the physicians that received the communication skills and bias mitigation training. The primary hypothesis is that physicians who receive both the communication skills and the bias mitigation training will have greater improvements in communication skills with the Black standardized caregiver (actor) compared with those who receive only the communication skills training. This registration is inclusive of phase 2 only as phase 2 is the clinical trial portion of this research. Phase 1 is not a clinical trial as it was an observational study that did not include an intervention. Phase 1 data was used to inform the structure and analysis of phase 2.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Communication and Bias Mitigation Training, Communication skills training for end-of-life care?
Research shows that training healthcare professionals in communication skills can improve their ability to discuss end-of-life care with patients and families, which is often a challenging area for many. Studies have found that such training can enhance the quality of communication, although the direct impact on patient-reported outcomes is still being explored.12345
Is Bias Mitigation Training for End-of-Life Care safe for humans?
The research articles reviewed focus on communication skills and disclosure of adverse events in healthcare, but they do not provide specific safety data for Bias Mitigation Training for End-of-Life Care. However, communication skills training generally involves non-invasive methods and is considered safe for participants.678910
How is the treatment 'Communication and Bias Mitigation Training' unique for end-of-life care?
This treatment is unique because it focuses on improving healthcare professionals' communication skills specifically for end-of-life care, which is often not adequately covered in standard training. It aims to address both communication and bias, helping professionals facilitate more effective and compassionate discussions with patients and their families during a critical time.1231112
Research Team
Elizabeth Chuang, MD
Principal Investigator
Montefiore Medical Center/Albert Einstein College of Medicine
Eligibility Criteria
This trial is for physicians specializing in oncology, critical care, hospitalist medicine, emergency medicine or geriatrics who frequently care for seriously ill patients. It's not open to those trained in Hospice and Palliative Medicine or doctors who spend less than 10% of their time with critically ill hospitalized patients.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Phase 1: Simulated Clinical Encounter
Physicians participate in a simulated clinical encounter with a standardized caregiver to assess communication behaviors and implicit bias.
Phase 2: Communication Training
Randomized training session to mitigate implicit bias and improve communication skills, including a VR experience and role-play exercises.
Follow-up
Participants are monitored for changes in communication behavior and bias mitigation effectiveness post-training.
Treatment Details
Interventions
- Communication and Bias Mitigation Training
- Communication skills training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montefiore Medical Center
Lead Sponsor
University of Nebraska Lincoln
Collaborator
Tulane University School of Medicine
Collaborator
Dartmouth College
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator